Journal of Nervous and Mental Disease 2012-11-01

Telescoping phenomenon in pathological gambling: association with gender and comorbidities.

Jon E Grant, Brian L Odlaug, Marc E Mooney

Index: J. Nerv. Ment. Dis. 200(11) , 996-8, (2012)

Full Text: HTML

Abstract

The course of pathological gambling (PG) in women has been described as having a later age of initiation but a shorter time to problematic gambling ("telescoped"). This study examined evidence for telescoping and its relationship with comorbidities. Seventy-one treatment-seeking individuals with PG underwent a diagnostic interview to examine gambling behaviors, age at initiation of gambling, and time from initiation to meeting criteria for PG. The women had a higher mean age at gambling initiation compared with that of the men (mean [SD] age, 31.3 [13.0] years, compared with 22.4 [7.9] years; p = 0.0003) and a significantly shorter time from initiation of gambling to meeting the criteria for PG (8.33 [8.7] years compared with 11.97 [9.1] years; p = 0.0476) after controlling for demographic and clinical variables. This study presents evidence for a gender-specific course of PG unrelated to psychiatric comorbidities and suggests a need for greater clinical focus on the gender differences of gambling behavior.


Related Compounds

Related Articles:

Real-time concurrent monitoring of apoptosis, cytosolic calcium, and mitochondria permeability transition for hypermulticolor high-content screening of drug-induced mitochondrial dysfunction-mediated hepatotoxicity.

2012-10-17

[Toxicol. Lett. 214(2) , 175-81, (2012)]

Capture compound mass spectrometry sheds light on the molecular mechanisms of liver toxicity of two Parkinson drugs.

2010-01-01

[Toxicol. Sci. 113(1) , 243-53, (2010)]

Physiological and behavioural responsivity to stress and anxiogenic stimuli in COMT-deficient mice.

2012-03-17

[Behav. Brain Res. 228(2) , 351-8, (2012)]

Orientation and cellular distribution of membrane-bound catechol-O-methyltransferase in cortical neurons: implications for drug development.

2011-10-07

[J. Biol. Chem. 286(40) , 34752-60, (2011)]

Tolcapone: a review of its use in the management of Parkinson's disease.

2005-01-01

[CNS Drugs 19(2) , 165-84, (2005)]

More Articles...